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Abstract
Background: Patients with cervical spondylosis myelopathy (CSM) and complicated with hypertension are often
experiencing a blood pressure decrease after taking cervical decompressive surgery in clinical observations, but
how this blood pressure reduction is associated with the surgery, which cut cervical sympathetic nervous, has never
been rigorously assessed. Thus, the purpose of this study is to investigate the effect of cervical decompressive
surgery on blood pressure among CSM patients with hypertension.
Methods/Design: The study will be a time series cohort study. Fifty eligible patients will be selected consecutively
from the Peking University First Hospital. Two 24-h ambulatory blood pressure measurement (ABPM) will be taken
before the surgery, apart by at least 3 days. The patients will be followed up for another two ABPMs at 1 and
3 months after the surgery.
We will recruit subjects with cervical spondylosis myelopathy meeting operation indications and scheduled for
receiving cervical decompressive surgery, aged 18–84 years, have a history of hypertension or office systolic blood
pressure ≥140 mmHg on initial screening, and willing to participate in the study and provide informed consent.
Exclusion criteria includes a history of known secondary hypertension, visual analogue scale (VAS) score ≥4, and
unable to comply with study due to severe psychosis.
The change in systolic ABPs over the four times will be analyzed to observe the overall pattern of the blood
pressure change in relation to the surgery, but the primary analysis will be the comparison of systolic ABP between
the 2nd and 3rd , 4th measurements (before and after the surgery). We will also calculate the regression-to-the-mean
adjusted changes in systolic ABP as sensitivity analysis. Secondary endpoints are the changes in 24 h ABPM diastolic
blood pressure, blood pressure control status, the use and dose adjustment of antihypertensive medication, and the
incidence of operative complications. Primary outcome analyses will be carried out using analysis of covariance, as
well as the first secondary endpoint.
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Discussion: This study will inform us the important knowledge about cervical sympathetic nervous system (SNS)
and blood pressure. Once confirmed, it may help to produce new method for control of hypertension, which is the
leading cause of death in the world.
Trial registration: The study is registered to Clinical Trials.gov (NCT02016768).
Keywords: Cervical spondylosis myelopathy, Cervical decompressive surgery, Hypertension, 24 h ambulatory blood
pressure measurement
Background
Hypertension is a major global health concern. It is esti-
mated that 30–40 % of the adult population in the devel-
oped world are suffering from hypertension [1, 2].
Moreover, incidence and prevalence of hypertension are
increasing, especially in developing countries. The effects
of current pharmacologic treatment of hypertension re-
main suboptimal in both developing and developed coun-
tries [3, 4]. The common causes responsible for the poor
control of high blood pressure are attributed to physicians’
attitudes and patient non-compliance to lifelong pharma-
cological therapy for asymptomatic hypertension [5–7].
Moreover, hypertension that remains uncontrolled in spite
of the use of 3 or more antihypertensive drugs has been
called resistant hypertension [8]. Clinical evidence indi-
cates that the risk of major cardiovascular events is higher
among patients with resistant hypertension than that
among patients with controlled blood pressure [5]. Thus,
developing novel approaches for management of hyper-
tension, especially for resistant hypertension, is an import-
ant issue for the future of the treatment of hypertension.
It is well known that sympathetic nerve fibers are rich
in cervical spinal tissues [9–11]. Yamada et al. [9] re-
ported that there was different sympathetic innervation
between the cervical dura mater and the posterior longi-
tudinal ligament. It seems reasonable that the compres-
sion or irritation of cervical dura mater and/or posterior
longitudinal ligament may cause an increase in blood
pressure or aggravate pre-existing hypertension among
patients with cervical spondylosis myelopathy.
Tamura [12] found that neck injury, such as whiplash,
may lead to the cranial symptoms of the Barré-Lieou
syndrome (including a group of symptoms such as head-
ache, vertigo, tinnitus and ocular problems), which may
result from irritation of the sympathetic nervous supply.
We hypothesize that the cervical sympathetic nerve is
also associated with the occurrence of resistant hyper-
tension and that cervical decompressive surgery may be
beneficial in blood pressure control among patients with
cervical spondylosis myelopathy [13]. The purpose of
this study is to investigate the effect of cervical decom-
pressive surgery on resistant hypertension based on a
novel mechanistic hypothesis of essential hypertension.
Methods and design
Study design and Setting
The study is a time series cohort study. Patients with
both cervical spondylosis myelopathy and hypertension
are invited to participate in the study and subsequently
receive cervical decompressive surgery. Patients are re-
cruited continuously by surgeons at the Department of
Orthopaedics, Peking University First Hospital in
which there are about 30–40 patients with both cer-
vical spondylosis myelopathy and hypertension each
year. These subjects will be followed up at 1 and
3 months post-operation after enrollment. The study
procedures and informed consent form have been
approved by the Institutional Review Boards of the
Peking University Health Science Center in Beijing,
China, and registered at NCT02016768. Figure 1
shows an overview of the most important procedures
in the study.
Participants
Inclusion criteria
The patients to be included in the study should meet the
following inclusion criteria:
1. Patients with cervical spondylosis myelopathy,
such as bilateral hand clumsiness and numbness,
walking unsteady, weakness in the limbs, muscular
dystrophy, increasing deep tendon reflex and
positive Hoffmann and Babinski signs; the
underlying diseases including multilevel cervical
spinal stenosis, ossification of posterior longitudinal
ligaments (OPLL), disc herniation, meeting
operation indications: spinal neurological symptoms
for at least 2 months, which are not cured by
conservative treatment or in progression, significant
spinal compression indicated by magnetic resonance
imaging.
2. Aged 18–84 years.
3. Plans for receiving cervical decompressive surgery.
4. A history of hypertension or office systolic blood
pressure ≥140 mmHg on initial screening.
5. Willing to participate in the study and sign informed
consent.
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Exclusion criteria
If one of the following criteria is met, patients will be
excluded from the study:
1. A history of known secondary hypertension.
2. Visual analogue scale (VAS) score ≥4.
3. Unable to comply with study due to sever
psychosis.
Recruitment and consent
The patients who suffer from cervical spondylosis myel-
opathy and plan for receiving cervical decompressive
surgery will be selected for potential participation by the
surgeons at the Department of Orthopedics. After con-
sultation with inpatients and outpatients and screening
their clinical information, the principal investigator of
the study (the surgeon) informs patients whether they
Fig. 1 Study measures and time points
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are eligible for the study. Informed consent is acquired
immediately after screening for every subject by the
principal investigator.
Withdrawal of individual subjects
Subjects can withdraw from the study at any time for any
reason without any consequences. The investigator can
also decide to release a subject from the study for medical
reasons. For every subject who decides to withdraw from
the study, the reasons for withdrawal will be recorded.
A total of 18 patients have given informed consent for
participation and been enrolled into the study from July
2014 to Oct 2015.
Cervical decompressive surgery
The cervical decompressive surgery will be done with
one of the following four operating methods: inter-
national standard anterior cervical discectomy and fu-
sion (standard Smith-Robinson technique, intervertebral
disc incised and removed to reduce pressure, interbody
fusion by implanting cervical interbody fusion cage), an-
terior cervical corpectomy and fusion (cervical corpect-
omy decompression, interbody fusion by implanting
titanium cage), posterior bilateral open-door decompres-
sion (modified Hemo anchored method) or one-side
open door decompression (modified Hirobayashi an-
chored method). The indications for anterior approach
are subjects with less than three levels disc herniation,
while for posterior approach are those with multilevel
cervical spinal stenosis and continuous or mixed OPLL.
Initial screening, assessment and follow-up
After providing informed consent, potential participants
will be asked standardized questions about their demo-
graphic characteristics and medical history (especially
for the history of hypertension and antihypertensive
therapy) at initial screening. In addition, office blood
pressure, VAS score and 24 h ambulatory blood pressure
measurement (ABPM) will also be measured and used
for checking inclusion/exclusion criteria (Fig. 2).
Eligible participants will be hospitalized for surgical
treatment, and a pre-operation visit and clinical evaluation
will be done before surgery, including antihypertensive
medication, vital signs, physical examination, laboratory
testing, spinal nerve function score and 24 h ABPM
(Fig. 2). It is required that there is at least 3 days apart be-
tween initial screening visit and pre-operation visit. As
soon as the operation condition is met, these subjects will
receive cervical decompressive surgery, and their oper-
ation notes and adverse events will be recorded in detail.
All subjects will be followed up at 1 and 3 months
after surgical operation, with antihypertensive medica-
tion recording, measurement of office blood pressure,
24 h ABPM and adverse events assessment collected at
each time. In addition, VAS, physical examination and
spinal nerve function score will be measured and col-
lected at 3 month follow-up.
Regular antihypertensive medication therapy will be
continued during the entire study period, however, the
investigator can adjust the antihypertensive medication
if necessary, according to treatment needs of individual
patients.
Study endpoints
The primary endpoint is estimated as the difference be-
tween systolic ABPM before surgery (2nd measurement)
and the systolic ABPM at 1 month and 3 month post-
operation (3rd and 4th measurement).
Four secondary endpoints were defined as: 1) The differ-
ence between diastolic ABPM before surgery and ABPM
diastolic blood pressure at 1 month and 3 month post-
operation; 2) control status of blood pressure at 1 month
and 3 month post-operation (blood pressure control is
achieved if systolic/diastolic blood pressure <140/90 mm
Hg, reducing systolic blood pressure by >20 mm Hg or re-
ducing diastolic blood pressure >5 mm Hg); 3) the use
and dose adjustment of antihypertensive medication; and
4) the incidence of operative complications, including
spinal nerve trauma, incision infection and fluid, pneumo-
nia and urinary system infection etc.
Sample size calculation
Based on previous study which explored the efficacy of
renal sympathetic denervation in treating hypertension,
we assume that for the current study the primary out-
come (the change of 24 h ABPM systolic blood pressure
from pre-operation to the measurement at 3 months
post-operation) has a standard deviation of 15 mm Hg
[14]. We wish to be able to detect a difference of 11 mm
Hg. Assuming a 20 % drop-out rate, a total of 50 partici-
pants are required to provide 90 % power, with the risk
of two-sided type І error of 0.01.
Statistical analysis
Analyses will be made using SAS statistical software
(version 9.3) by researchers at the Peking University
Clinical Research Institute. The change in systolic
ABPMs over the four times will be analyzed to observe
the overall pattern of the blood pressure change in rela-
tion to the surgery, but the primary analysis will be the
comparison of systolic ABPM between the 2nd and 3rd, 4th
measurements (before and after the surgery). We will also
calculate the regression-to-the-mean adjusted changes in
systolic ABPMs as sensitivity analysis. Primary endpoint
analyses and the change in systolic ABPMs over the four
times will be carried out using analysis of covariance, as
well as the first secondary endpoint (the change of 24 h
ABPM diastolic blood pressure). Descriptive statistics will
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be used to summarize control status of blood pressure,
the use and dose adjustment of antihypertensive medica-
tion and the incidence of operative complications.
Discussion
The etiology and mechanism of essential hypertension re-
mains unclear. Non-operative methods of essential hyper-
tension treatment including antihypertensive pharmacologic
drugs are still unsatisfactory [5, 8]. In the past several years,
a new procedure named renal denervation had been shown
to be safe and effective in controlling hypertension, sup-
porting that the sympathetic nervous system (SNS) activity
is critical in regulating blood pressure [6, 7]. Recently, we
have proposed a novel hypothesis that cervical spondylotic
myelopathy may be an important etiology of essential
hypertension which has been termed as cervicogenic hyper-
tension [13]. In our previous study, we found that the high
blood pressure in 12 out of 30 (40 %) hypertensive patients
Fig. 2 Observation, assessment, and follow-up schedule
Liu et al. BMC Surgery  (2016) 16:2 Page 5 of 7
was reduced to normal levels following the cervical decom-
pressive surgery, which resulted in a termination of the an-
tihypertensive medications. Furthermore, the high and
unstable blood pressure in the other 15 patients became
stabilized and was well controlled by antihypertensive drugs
after cervical decompressive surgery [13]. Recently, Peng
et al. reported two cases of cervical spondylosis with hyper-
tension [15]. After anterior cervical discectomy and fusion,
the blood pressure of both the two patients remain normal
without hypertensive medications [15]. Also, we speculate
that renal denervation only destructs the network of SNS,
and that the diseased cervical SNS has a greater impact on
initiating and increasing SNS activity, as it may be closer to
central nervous system than the normal renal SNS.
Through long–term clinical observations, we have found
that high blood pressure or fluctuated blood pressure
among many patients decreased substantially or became
stable post-operatively. Therefore, we infer that cervical
decompressive surgery may be a novel alternative in treat-
ing hypertension and will effectively reduce blood pressure
in patients with cervicogenic hypertension. Therefore, a
substantial number of patients with both hypertension and
cervical spondylosis may benefit from this approach as the
decrease in the quantity and/or dose of antihypertensive
drugs would subsequently lead to fewer side effects from
them. Regarding the rationale for the reduction on blood
pressure, we speculate that the compression or irritation
of the dura mater and the posterior longitudinal ligament
of the cervical spine may increase the sympathetic nervous
activation. This discharge may pass through the ganglia
and the sympathetic trunk to the postganglia fibers arriv-
ing at the target organ, such as the vertebral artery and the
blood vessels and subsequently induce hypertension.
Decompressive cervical surgery, either anterior cervical
discectomy and fusion or posterior laminoplasty, may
withdraw any compression of the dura and the posterior
longitudinal ligament and thus the sympathetic irritation
will be relieved leading to a decrease of blood pressure.
Our study has a number of limitations. This is not a ran-
domized controlled clinical trial, factors such as placebo
and Hawthorne effects cannot be ruled out entirely. How-
ever, we tried to measure blood pressure two times both
before and after the surgery, these multiple measurements
would help to better understand if the change in blood
pressure is attributed to the surgery or purely to the regres-
sion to the mean. Although the randomized controlled trial
is the gold standard study design, it is unethical to conduct
such a trial considering the inappropriateness of treating
hypertension with a cervical decompressive surgery. In our
opinion, the study still gains important scientific informa-
tion. Once our hypothesis is approved, it will provide an in-
novative mechanism of hypertension development, which
may lead to the development of new methods of hyperten-
sion treatment and prevention.
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